Navigation Links
Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
Date:5/9/2008

ndard therapy or for which no curative standard therapy exists. The primary objectives of the trial include determining the Minimum Effective Immunomodulatory Dose (MED) of cyclophosphamide to obtain successful immune modulation. Secondary objectives include determining the safety profile of the combination and gathering any evidence of anti-tumour activity.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com.

Ref:

Clin. Cancer Res. 2008 14:259-269

Cancer Gene Ther. 2006 Aug; 13(8): 815-8

Cancer Res, 2003 Jan 15; 63(2):348-53

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the U.K. combination REOLYSIN(R)/cyclophosphamide clinical trial, and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the tolerability of REOLYSIN(R) outside a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting
2. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
3. Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells
4. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
5. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting
6. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Pediatric Sarcomas at AACR Annual Meeting
7. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Paclitaxel and Carboplatin Trial
8. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial
9. Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent
10. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
11. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 Rust removal is one of ... home items could be damaged. To help rust contractors make ... its no-scrubbing rust remover it called Rusterizer. It ... with 10% discount. , My Cleaning Products explained that rust ... or by staining them. The first one, it said, ...
(Date:5/16/2013)... May 16, 2013 ISPE ... A. Myers, CAE, to the newly created position ... new role, Myers will be responsible for stimulating ... production strategies, advancing the Society’s Member-led and staff-driven ... continuing to refine organizational, membership and product marketing. ...
(Date:5/16/2013)... 2013 Cambridge Healthtech Institute will host ... 2013 at the Renaissance Waterfront Hotel in Boston, MA. ... close-up look at the current strategies and innovations for ... Leaders in the field will reveal how their ... with greater specificity and efficiency. , “In this age ...
(Date:5/16/2013)... HAYWARD, Calif. , May 16, 2013 ... University, Beijing , and the ... www.magceutics.com ) have demonstrated a novel therapy for reversing ... brain magnesium levels, they find significant cognitive improvement in ... to demonstrate a mechanism for reversing cognitive decline for ...
Breaking Biology Technology:Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3
... of Energy,s Lawrence Berkeley National Laboratory (Berkeley Lab) and ... first scanning tunneling spectroscopy of graphene flakes equipped with ... a series of surprising insights into the electronic behavior ... unexpected gap-like feature in the energy spectrum of electrons ...
... Schering-Plough,Corporation (NYSE: SGP ) has rescheduled ... review the sales and earnings results for the ... 8 a.m. today. The quarterly,financial results will be ... of,the New York Stock Exchange., Schering-Plough made ...
... presentations to be hosted at 2008 American Association for ... Clinical Chemistry Annual ... invited investors to participate in the Company,s Analyst,Reception which is ... for Clinical Chemistry (AACC) Annual Meeting., Cepheid speakers will ...
Cached Biology Technology:A phonon floodgate in monolayer carbon 2A phonon floodgate in monolayer carbon 3A phonon floodgate in monolayer carbon 4A phonon floodgate in monolayer carbon 5Schering-Plough Reschedules Time of Conference Call, Webcast for 2008 Second Quarter Earnings to Later Today 2Cepheid to Webcast Analyst Event 2
(Date:5/16/2013)... so many sports players and athletes choose to wear ... to be published in Psychological Science , a ... it may have to do with their testosterone levels. ... Farrelly of the University of Sunderland and colleagues, demonstrated ... a competitive task had higher testosterone levels than other ...
(Date:5/16/2013)... the bone marrow in the liver, the spleen ... show that a specific type of immune cell facilitates ... hematopoiesis is essential for the function of the immune ... the liver and the spleen. Later the process is ... serves as the sole source of blood cells for ...
(Date:5/16/2013)... don,t ponder our pulses outside of the gym. But doctors ... heart health. , Zhenan Bao, a professor of chemical engineering ... dollar bill and no wider than a postage stamp. The ... wrist, is sensitive enough to help doctors detect stiff arteries ... used to continuously track heart health and provide doctors a ...
Breaking Biology News(10 mins):High-testosterone competitors more likely to choose red 2Herpes infections: Natural killer cells activate hematopoiesis 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3
... A new partnership between the U.S. Environmental Protection Agency,s ... Gund Institute for Ecological Economics at the University of ... costs and benefits of actions that alter ecosystem services ... clean air and water, erosion and flood control, soil ...
... the Max-Planck-Institute for Molecular Genetics in Berlin (MPI MolGen), ... and Ann Arbor, MI, USA, applied next generation sequencing ... the human transcriptome. , Deep sequencing of transcripts from ... and variability of the human transcriptome. They found ...
... suitable carrier for an oral vaccine against Alzheimer,s disease, ... of Bioscience and Biotechnology (KRIBB) in Korea and colleagues ... Science at Wonkwang University. Although their research (1), just ... is still in the early stages, it is a ...
Cached Biology News:US EPA, UVM's Gund Institute team up to develop new ways to understand ecosystem services 2Deep sequencing study reveals new insights into human transcriptome 2Can tomatoes carry the cure for Alzheimer's? 2
This device is designed to run four simultaneous separations with the following StemSep ; column sizes: 0.3in., 0.5in., and 0.6in.. Depending on the column size, a range of 2x10 7 - 1.5 x 10 9 cell...
... 20-HETE is a cytochrome P450 (CYP450) ... in the renal and cerebral vasculature. In ... that mediates pressure-induced autoregulatory vasoconstriction. 20-HETE is ... concentration of free 20-HETE (20-40 pg/ml in ...
... Mutagenesis System enables you to insert a ... target DNA by in vitro transposition. It ... randomly into the DNA target. Target DNA ... purified,chromosomal DNA, depending on your interests (6-8). ...
... (JNK) is one of the several main ... used as a sensitive reporter for studying ... 1000-fold increase in sensitivity in comparison to ... luciferase catalyzes the oxidative carboxylation of luciferin, ...
Biology Products: